Literature DB >> 9202292

Dramatic increase of the RNA editing for glutamate receptor subunits during terminal differentiation of clonal human neurons.

F Lai1, C X Chen, V M Lee, K Nishikura.   

Abstract

RNA editing plays an important role in determining physiological characteristics of certain glutamate-gated receptor (GluR) channels such as Ca2+ permeability and desensitization kinetics. In one case, the editing changes a gene-encoded glutamine (Q) to an arginine (R) codon located in the channel-forming domain of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunit GluR-B and also the kainate receptor subunits GluR5 and GluR6. Another case of RNA editing alters an arginine (R) to a glycine (G) codon at a position termed the "R/G" site of AMPA subunits GluR-B, C, and D. Double-stranded RNA-specific adenosine deaminases (DRADA) have been implicated as agents involved in the editing. By using a human teratocarcinoma cell line, NT2, we investigated the change of the RNA editing of GluR subunits in conjunction with the expression of two DRADA members, DRADA1 and DRADA2 genes, during neuronal differentiation. Whereas Q/R and R/G site RNA editing both become progressively activated in differentiating NT2 cells, the expression of the two DRADA genes can already be detected even in the undifferentiated NT2 cells. Development of the editing machinery appears to require, in addition to DRADA enzymes, a currently unidentified mechanism(s) that may become activated during neuronal differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202292     DOI: 10.1046/j.1471-4159.1997.69010043.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.

Authors:  C X Chen; D S Cho; Q Wang; F Lai; K C Carter; K Nishikura
Journal:  RNA       Date:  2000-05       Impact factor: 4.942

Review 2.  Activity regulation of adenosine deaminases acting on RNA (ADARs).

Authors:  Cesare Orlandi; Alessandro Barbon; Sergio Barlati
Journal:  Mol Neurobiol       Date:  2011-11-20       Impact factor: 5.590

Review 3.  Non-coding RNAs in the nervous system.

Authors:  Mark F Mehler; John S Mattick
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

4.  Extensive adenosine-to-inosine editing detected in Alu repeats of antisense RNAs reveals scarcity of sense-antisense duplex formation.

Authors:  Yukio Kawahara; Kazuko Nishikura
Journal:  FEBS Lett       Date:  2006-03-24       Impact factor: 4.124

5.  Editing of the serotonin 2C receptor pre-mRNA: Effects of the Morris Water Maze.

Authors:  Yunzhi Du; Melissa Stasko; Alberto C Costa; Muriel T Davisson; Katheleen J Gardiner
Journal:  Gene       Date:  2007-01-12       Impact factor: 3.688

6.  RNA editing activity is associated with splicing factors in lnRNP particles: The nuclear pre-mRNA processing machinery.

Authors:  O Raitskin; D S Cho; J Sperling; K Nishikura; R Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

Review 7.  Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis.

Authors:  Shin Kwak; Yukio Kawahara
Journal:  J Mol Med (Berl)       Date:  2004-12-29       Impact factor: 4.599

8.  A mammalian reporter system for fast and quantitative detection of intracellular A-to-I RNA editing levels.

Authors:  Willemijn M Gommans; Jill McCane; Gregory S Nacarelli; Stefan Maas
Journal:  Anal Biochem       Date:  2010-01-04       Impact factor: 3.365

9.  Differential inhibition of RNA editing in hepatitis delta virus genotype III by the short and long forms of hepatitis delta antigen.

Authors:  Qiufang Cheng; Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Identification of a selective nuclear import signal in adenosine deaminases acting on RNA.

Authors:  Stefan Maas; Willemijn M Gommans
Journal:  Nucleic Acids Res       Date:  2009-07-17       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.